SLAMF7 and Miyoshi myopathy: Soluble SLAMF7 (sSLAMF7) is detected in MM patients rather than normal individuals [24] and could promote MM cell growth via activating the SHP-2 and ERK signaling pathways via homophilic interaction [57].